Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

Author: Helisch Andreas   Förster Gregor   Reber Helmut   Buchholz Hans-Georg   Arnold Rudolf   Göke Burkhard   Weber Matthias   Wiedenmann Bertram   Pauwels Stanislas   Haus Ulrike   Bouterfa Hakim   Bartenstein Peter  

Publisher: Springer Publishing Company

ISSN: 1619-7070

Source: European Journal of Nuclear Medicine and Molecular Imaging, Vol.31, Iss.10, 2004-10, pp. : 1386-1392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content